Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy.
Pei-Wei HuangChing-Fu ChangChia-Yen HungShun-Wen HsuehPei-Hung ChangKun-Yun YehJen-Shi ChenYen-Yang ChenChang-Hsien LuYu-Shin HungWen-Chi ChouPublished in: Cancer medicine (2019)
The results of our study supported the application of the GS model as a general prognostic tool for patients with pancreatic cancer receiving first-line palliative chemotherapy with gemcitabine-based regimens.